Genocea Biosciences (Cambridge, MA), a clinical-stage biotechnology company focused on therapeutic and prophylactic vaccines for infectious diseases, closed a $30M Series C financing. Participants include Bill & Melinda Gates Foundation, Central Valley Fund, Johnson & Johnson Development Corp., Skyline Ventures, MP Healthcare Venture Management, Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga […]
Okairos (Switzerland) a clinical-stage biopharmaceutical company developing T-cell vaccines against infectious diseases such as malaria, HIV, hepatitis C and influenza, closed a $20.8M Series B financing. Participants include Versant Ventures, Boehringer Ingelheim Venture Fund, BioMedPartners, Life Science Partners and Novartis Venture Fund.
Amyris Biotechnologies (Emeryville, CA) a development-stage biofuels company focused on metabolic pathway transformations of plant-based feedstocks into different isoprenoids, closed a $24.8M Series C financing. Participants include Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPGBiotech.